Arman Kacharian
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
Arman Kacharian
Jun 8, 2024, 11:33 |
Blog
Nataliya Kovalchuk: Grateful to ASCO ECO leadership for hosting Ukrainian delegation at ASCO24
Nataliya Kovalchuk, Clinical Associate Professor at Stanford University School of Medicine, shared a post on…
Jun 8, 2024, 03:53 |
Societies
25 Posts From ASCO24 You Should Not Miss!
The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting was held from May 31st…
Jun 7, 2024, 01:06 |
Blog
Arman Kacharian: We appreciate all the partners who stood by us through these challenging times
Arman Kacharian, Head of the Innovations Unit at Ministry of Health of Ukraine, shared on…
Jun 3, 2024, 10:34 |
Blog
Ukrainian cancer specialists at the ASCO Congress - European Cancer Organisation
European Cancer Organisation (ECO) shared on LinkedIn: . "Today, ECO President Csaba Dégi…
Jun 2, 2024, 09:09 |
Societies
15 Posts From ASCO24 Day 2 You Should Not Miss!
The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting is being held from May…
Feb 10, 2024, 08:23 |
Blog
Maria Babak: Last December, I was privileged to speak at the Global Summit on War and Cancer
Maria (Masha) Babak, Assistant Professor at City University of Hong Kong, shared on LinkedIn: "Flashback…
Dec 17, 2023, 11:28 |
Blog
Elen Baloyan: Key takeaways from the Global Summit on War and Cancer
Elen Baloyan, Medical Oncology Fellow at the Yeolyan Hematology and Oncology Center and the Managing Editor…
Dec 10, 2023, 05:08 |
Societies
Global Summit on War and Cancer: Agenda
Our Global Summit on War and Cancer brings together experts, researchers, and advocates from around…
All:
8
Posts:
1 - 10
New Paper Alert! Long-Term Benefits of Dabrafenib-Trametinib in Stage III Melanoma: 8-Year COMBI-AD Trial Results
We mourn the loss of our Ivy Elkins
FDA grants accelerated approval to adagrasib with cetuximab for KRAS G12C-mutated colorectal cancer
Rob Winn: Honored to receive the ASCO Allen Lichter Visionary Leader Award
Yardena Samuels: An absolute honor to be elected as the next EACR president
Facebook
RSS Feed
Twitter
Linkedin
Youtube